Health & Biotech
The Calmer Co jumps 100pc on strong momentum in May, driven by eCommerce sales
ASX Health Stocks: Genetic Signatures gets FDA approval; Optiscan unveils new device
‘Significant milestone’: Optiscan soars on new InVue imaging device for precision surgery
ASX Health Winners in May: LTR Pharma leads, and why hopes are high for biotech stocks this year
AdAlta secures $1.9m from exercise of options to advance critical discovery programs
ASX Health Stocks: INOVIQ pops 45pc after revealing breakthrough exosome therapy to kill breast cancer
ScoPo’s (actually Wilkie’s) Powerplays: ASX health stocks fall but Dimerix and Avita soar
PharmAust puts experienced hands back on its rudder
ASX Health Stocks: AVITA soars on FDA green light for RECELL GO System
EZZ inks key five year sales deal expanding distribution in China and key markets in Asia
‘Stable, material revenue generating business:’ Melodiol’s Canadian subsidiary maintains strong progress
ASX Health Stocks: Cleo up 30pc and GTG up 13pc after cancer test kit progress
ASX Health Stocks: PainChek wins European patent; Phase 3 Trial set to begin for Opthea
Bioxyne highlights risks of unregulated psychedelic use
Dimerix strikes $120m licensing deal for kidney drug in Middle East
ASX Health Stocks: EMV’s AI algo shows promise, and Telix submits new FDA application
ScoPo’s Powerplays: ASX health stocks fall as Sonic cuts FY24 profit guidance
Featured Health & Biotech Stocks
Health & Biotech
Healthcare stocks are as varied as the solutions they are working to solve. The sector covers biotech stocks developing breakthrough pharmaceutical drugs and vaccines to medtech companies launching the latest and greatest medical devices they hope will change the face of healthcare.
Even the ‘budding’ medical cannabis industry is in the mix as researchers explore new applications and treatments.
If you want to know what’s happening with emerging health stocks on the ASX, Stockhead has you covered, with daily stock news, expert insight and research. You can also recap broader industry trends and recent share price movements across the sector in our regular ‘Check Up’ feature.
Accurate, up-to-date news stories are important, especially in the health sector where progress is often slow and risk often high. That’s why we’re focused on helping small cap investors make sense of the medical jargon.
